565 related articles for article (PubMed ID: 12136373)
1. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
Hedenmalm K; Spigset O
Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
[TBL] [Abstract][Full Text] [Related]
2. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
Maj S; Centkowski P
Med Sci Monit; 2004 Sep; 10(9):PI93-5. PubMed ID: 15328493
[TBL] [Abstract][Full Text] [Related]
4. [The use of metamizole as a risk factor in the occurrence of agranulocytosis].
Vlakhov V; Bakracheva N; Popova L
Vutr Boles; 1988; 27(2):80-5. PubMed ID: 3046147
[TBL] [Abstract][Full Text] [Related]
5. Population-based drug-induced agranulocytosis.
Ibáñez L; Vidal X; Ballarín E; Laporte JR
Arch Intern Med; 2005 Apr; 165(8):869-74. PubMed ID: 15851637
[TBL] [Abstract][Full Text] [Related]
6. Agranulocytosis associated with dipyrone (metamizol).
Ibáñez L; Vidal X; Ballarín E; Laporte JR
Eur J Clin Pharmacol; 2005 Jan; 60(11):821-9. PubMed ID: 15580488
[TBL] [Abstract][Full Text] [Related]
7. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012.
Stammschulte T; Ludwig WD; Mühlbauer B; Bronder E; Gundert-Remy U
Eur J Clin Pharmacol; 2015 Sep; 71(9):1129-38. PubMed ID: 26169297
[TBL] [Abstract][Full Text] [Related]
8. [Surgery, dipyrone, and agranulocytosis in Latin America].
Sánchez Medal L
Sangre (Barc); 1997 Oct; 42(5):343-4. PubMed ID: 9424731
[No Abstract] [Full Text] [Related]
9. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
Hoffmann F; Bantel C; Jobski K
Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718
[TBL] [Abstract][Full Text] [Related]
10. Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports.
Blaser LS; Tramonti A; Egger P; Haschke M; Krähenbühl S; Rätz Bravo AE
Eur J Clin Pharmacol; 2015 Feb; 71(2):209-17. PubMed ID: 25401171
[TBL] [Abstract][Full Text] [Related]
11. [Agranulocytosis and metamizole].
Hoerder U; König HJ; Hartwich G
Dtsch Med Wochenschr; 1982 Dec; 107(50):1923-6. PubMed ID: 7140576
[TBL] [Abstract][Full Text] [Related]
12. Blood dyscrasias induced by psychotropic drugs.
Stübner S; Grohmann R; Engel R; Bandelow B; Ludwig WD; Wagner G; Müller-Oerlinghausen B; Möller HJ; Hippius H; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S70-8. PubMed ID: 15052517
[TBL] [Abstract][Full Text] [Related]
13. [Agranulocytosis induced by metamizole and its management with granulocyte growth factor].
Celeketić D; Trpković A; Cvetković Z
Vojnosanit Pregl; 2005 Jan; 62(1):79-82. PubMed ID: 15715354
[TBL] [Abstract][Full Text] [Related]
14. Causes of agranulocytosis in a hospital population: identification of dipyrone as an important causative agent.
Shinar E; Hershko C
Isr J Med Sci; 1983 Mar; 19(3):225-9. PubMed ID: 6853118
[TBL] [Abstract][Full Text] [Related]
15. [Agranulocytosis caused by metamizol. Anesthetic attitude].
Prieto Alvarez MP; Fuentes Bellido JG; López Cebollada J; Escoda Teigell L; Lorenzo Foz JP
Rev Esp Anestesiol Reanim; 1998; 45(6):248-50. PubMed ID: 9719723
[TBL] [Abstract][Full Text] [Related]
16. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
Lampl C; Likar R
Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
[TBL] [Abstract][Full Text] [Related]
17. Chronic use of metamizole: not so safe after all?
Vuik FE; Koehestanie P; Herbers AH; Terhaar Sive Droste JS
Neth J Med; 2017 Mar; 75(2):81-83. PubMed ID: 28276328
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced agranulocytosis. A survey of twenty-three episodes.
Mintz U; Shaklai M; Pinkhas J; de Vries A
Med Interne; 1975; 13(3):205-8. PubMed ID: 52883
[TBL] [Abstract][Full Text] [Related]
19. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.
Huber M; Andersohn F; Sarganas G; Bronder E; Klimpel A; Thomae M; Konzen C; Kreutz R; Garbe E
Eur J Clin Pharmacol; 2015 Feb; 71(2):219-27. PubMed ID: 25378038
[TBL] [Abstract][Full Text] [Related]
20. Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance Study.
Andersohn F; Bronder E; Klimpel A; Garbe E
Am J Hematol; 2004 Nov; 77(3):316-8. PubMed ID: 15495238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
